About Us
DNAPrint genomics is a young e-biotech
company based in southwest Florida. We
are developing an informatics platform
system that will provide dynamic
solutions for disease gene discovery,
genetic predisposition and genetic
analysis testing. Our work has real-life
application to the germinating field of
Personalized Medicine and will help lay
the foundation for a brand-new area of
medical research called Phenomics.
The PhenomeSM platform system that we are developing will help
identify an individual predisposed to develop cancer before the
onset of illness so that lifestyles can be altered and/or preventative
measures taken. It will be used to identify individuals who are
incompatible with certain drug treatments before the drugs are
prescribed and damage is done. It will be used to tease out
important genetic determinants associated with complex genetic
diseases, so that drugs can be developed to target these genes.
Our aim is ambitious. By partnering our platform with
biotech/pharma, we will participate in the downstream profits
generated from pharmaceutical products our platform has enabled.
By marketing our platform directly to the public, we intend to make
comprehensive genotype screening solutions accessible to people
all over the world via the internet. Our system will enable a more
holistic approach to using genomics information to improve peoples
lives.
The patient of the future will have more information and power than
ever imagined. The human genome project, the internet and recent
technological advancements all contribute to make this possible, and
we intend to take advantage of these synergies to become the
primary conduit for the generation and distribution of personalized
genetic information.
Copyright DNAprint genomics © 2000
